Sep-11-25 07:57AM
|
|
06:30AM
|
|
Sep-10-25 08:56AM
|
|
07:20AM
|
|
06:20AM
|
|
04:53AM |
Loading… |
04:53AM
|
|
Sep-05-25 09:45AM
|
|
08:50AM
|
|
06:05AM
|
|
06:00AM
|
|
Sep-04-25 02:20PM
|
|
12:15PM
|
|
06:00AM
|
|
Sep-03-25 08:49AM
|
|
05:55AM
|
|
02:55AM |
Loading… |
02:55AM
|
|
Sep-02-25 11:13AM
|
|
11:06AM
|
|
08:45AM
|
|
Sep-01-25 12:11PM
|
|
Aug-30-25 04:05AM
|
|
Aug-29-25 11:22AM
|
|
07:00AM
|
|
Aug-28-25 03:17PM
|
|
08:48AM
|
|
Aug-26-25 09:50AM
|
|
Aug-25-25 05:41PM
|
|
05:00AM
|
|
04:04AM
|
|
Aug-24-25 11:14AM
|
|
07:00AM |
Loading… |
Aug-23-25 07:00AM
|
|
Aug-22-25 09:53AM
|
|
08:12AM
|
|
04:10AM
|
|
Aug-21-25 04:29PM
|
|
08:15AM
|
|
08:05AM
|
|
08:05AM
|
|
Aug-20-25 06:06PM
|
|
04:18PM
|
|
11:20AM
|
|
10:30AM
|
|
10:30AM
|
|
10:15AM
|
|
09:40AM
|
|
09:20AM
|
|
08:05AM
|
|
03:03AM
|
|
Aug-19-25 05:01PM
|
|
04:33PM
|
|
04:25PM
|
(The Wall Street Journal) |
04:02PM
|
(Investor's Business Daily) |
03:41PM
|
|
02:59PM
|
|
01:45PM
|
(The Wall Street Journal) |
12:21PM
|
|
12:05PM
|
|
12:01PM
|
|
11:40AM
|
|
11:21AM
|
|
09:48AM
|
|
09:45AM
|
|
09:35AM
|
(The Wall Street Journal) |
09:30AM
|
|
09:10AM
|
(Investor's Business Daily) |
08:46AM
|
|
08:39AM
|
|
08:36AM
|
|
07:55AM
|
|
07:41AM
|
|
07:27AM
|
|
07:26AM
|
|
06:52AM
|
(Associated Press Finance) |
06:46AM
|
|
06:45AM
|
|
06:32AM
|
|
05:59AM
|
|
05:45AM
|
(The Wall Street Journal) |
04:57AM
|
|
04:05AM
|
|
03:14AM
|
(The Wall Street Journal) |
Aug-18-25 04:31PM
|
|
Aug-17-25 07:35AM
|
|
Aug-15-25 04:32PM
|
|
04:32PM
|
|
10:00AM
|
|
Aug-14-25 06:00PM
|
|
05:45PM
|
|
04:15PM
|
|
10:25AM
|
|
09:15AM
|
|
08:33AM
|
|
06:00AM
|
|
04:04AM
|
|
Aug-13-25 09:21AM
|
|
08:37AM
|
|
07:32AM
|
|
06:05AM
|
|
Aug-12-25 05:10PM
|
|
12:30PM
|
|
|
|
|
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland. |  |
|
|
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
KIIL HARRY SKIP | EVP & President Cardiovascular | Sep 03 '25 | Sale | 91.58 | 8,605 | 788,048 | 35,615 | Sep 05 04:18 PM | KIIL HARRY SKIP | Officer | Sep 03 '25 | Proposed Sale | 91.58 | 8,605 | 788,049 | | Sep 03 03:23 PM | Jellison William R | Director | Aug 22 '25 | Buy | 92.73 | 2,500 | 231,825 | 2,500 | Aug 25 05:18 PM | Jellison William R | Director | Aug 25 '25 | Buy | 92.37 | 2,500 | 230,925 | 5,000 | Aug 25 05:18 PM | Walter Matthew R. | SVP, Chief HR Officer | Aug 01 '25 | Option Exercise | 23.91 | 3,142 | 75,114 | 32,804 | Aug 04 04:21 PM | Wall Brett A. | EVP & Pres Neuroscience | Aug 01 '25 | Option Exercise | 0.00 | 15,249 | 0 | 66,531 | Aug 04 04:20 PM | Smith Gregory L | EVP Global Ops & Supply Chain | Aug 01 '25 | Option Exercise | 0.00 | 11,328 | 0 | 83,071 | Aug 04 04:19 PM | Martha Geoffrey | Chairman and CEO | Aug 01 '25 | Option Exercise | 32.21 | 98,324 | 3,166,800 | 284,923 | Aug 04 04:18 PM | Marinaro Michael | EVP, Pres MedSurg and Americas | Aug 01 '25 | Option Exercise | 25.24 | 9,661 | 243,828 | 57,628 | Aug 04 04:17 PM | KIIL HARRY SKIP | EVP & President Cardiovascular | Aug 01 '25 | Option Exercise | 0.00 | 10,457 | 0 | 51,775 | Aug 04 04:16 PM | Blomquist Denise L. | Chief Accounting Officer | Aug 01 '25 | Option Exercise | 32.22 | 518 | 16,692 | 12,671 | Aug 04 04:15 PM | Salmon Sean | Officer | Jun 06 '25 | Proposed Sale | 86.81 | 18,378 | 1,595,469 | | Jun 06 02:43 PM | Walter Matthew R. | SVP, Chief HR Officer | Jan 27 '25 | Option Exercise | 74.84 | 1,337 | 100,061 | 26,997 | Jan 28 05:10 PM | Marinaro Michael | EVP & President, Surgical OU | Jan 27 '25 | Option Exercise | 74.84 | 2,345 | 175,500 | 43,323 | Jan 28 05:09 PM | Martha Geoffrey | Chairman and CEO | Jan 27 '25 | Option Exercise | 74.84 | 34,741 | 2,600,016 | 216,954 | Jan 28 05:07 PM | Wall Brett A. | EVP & Pres Neuroscience | Jan 24 '25 | Option Exercise | 78.00 | 12,437 | 970,086 | 53,416 | Jan 27 05:35 PM | Wall Brett A. | EVP & Pres Neuroscience | Jan 24 '25 | Sale | 90.00 | 12,437 | 1,119,330 | 40,979 | Jan 27 05:35 PM | Wall Brett A. | Officer | Jan 24 '25 | Proposed Sale | 90.00 | 12,437 | 1,119,330 | | Jan 24 02:34 PM | Wall Brett A. | EVP & Pres Neuroscience | Jan 08 '25 | Option Exercise | 74.84 | 6,850 | 512,654 | 50,558 | Jan 10 04:48 PM | Wall Brett A. | EVP & Pres Neuroscience | Jan 08 '25 | Sale | 80.41 | 9,850 | 792,038 | 40,708 | Jan 10 04:48 PM | Wall Brett A. | Officer | Jan 08 '25 | Proposed Sale | 80.41 | 9,850 | 792,038 | | Jan 08 09:52 AM | PARKHILL KAREN L | Former Director | Oct 31 '24 | Proposed Sale | 89.73 | 30,000 | 2,691,794 | | Oct 31 03:21 PM | PARKHILL KAREN L | Former Director | Oct 30 '24 | Proposed Sale | 90.58 | 15,000 | 1,358,740 | | Oct 30 04:11 PM | PARKHILL KAREN L | Former BOD | Oct 29 '24 | Proposed Sale | 91.16 | 15,000 | 1,367,348 | | Oct 29 03:26 PM | PARKHILL KAREN L | Former Director | Oct 24 '24 | Proposed Sale | 92.49 | 22,712 | 2,100,633 | | Oct 24 04:01 PM | PARKHILL KAREN L | Former Director | Oct 23 '24 | Proposed Sale | 91.76 | 23,848 | 2,188,205 | | Oct 23 04:30 PM | PARKHILL KAREN L | Former BOD | Oct 18 '24 | Proposed Sale | 91.74 | 48,825 | 4,479,310 | | Oct 18 04:24 PM | PARKHILL KAREN L | Former BOD | Oct 17 '24 | Proposed Sale | 89.87 | 55,179 | 4,958,718 | | Oct 17 03:35 PM |
|